AiCure

Awards & Advancement

MEI Pharma adds David Urso as senior VP of Corporate Development, General Counsel

Friday, April 11, 2014 01:12 PM

MEI Pharma, an oncology company focused on the clinical development of novel therapies for cancer, has appointed David Urso senior vice president of Corporate Development and General Counsel. Urso joins MEI Pharma with more than two decades of experience in the life science industry, most recently as chief operating officer and general counsel at Tioga Pharmaceuticals, a company he co-founded in 2005 as a principal at Forward Ventures.

More... »


TrialNetworks wins Disruptive Technology and Innovator of the Year Award

Friday, April 11, 2014 11:37 AM

TrialNetworks and its Clinical Trial Optimization System won the Disruptive Innovator and Technology of the Year award from Partnerships in Clinical Trials 2014. The award honors an individual or a company with a new disruptive technology platform that has increased the efficiency and quality of clinical trials. TrialNetworks technology is used by companies including Merck, Biogen Idec, Ariad Pharmaceuticals and Infinity Pharmaceuticals to optimize clinical operations from startup through closeout.

More... »

Subscribe to The CenterWatch Monthly

Medidata wins award for innovative mobile app that engages patients in clinical trials

Thursday, April 3, 2014 11:38 AM

Medidata, a global provider of cloud-based solutions for clinical research in life sciences, won the Patient Engagement App Challenge (large organization category) at the 23rd Annual Partnerships in Clinical Trials Conference with a unique mobile app. The award recognizes Engage, Medidata’s app prototype, for its potential to positively transform the clinical trial experience for study participants at a time when capturing the voice of the patient is becoming increasingly important.

More... »

Icon awarded best CRO at World Vaccines Congress 2014

Thursday, April 3, 2014 11:33 AM

Icon,a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has been named Best Clinical Research Organization in the Vaccine Industry Excellence (ViE) Awards.

More... »

Glythera makes appointments to support company expansion

Thursday, April 3, 2014 11:26 AM

Glythera, a biotechnology company specializing in the development of next generation bio-therapeutics, including Antibody Drug Conjugates,  through the application of its proprietary linker and stable glycan technologies PermaLink and PermaCarb, has appointed of Nigel Burns as non-executive director and Ian Evetts as commercial director. Glythera has recently validated data from their core technologies and the addition of Burns and Evetts coincides with the company’s expansion plan exploring new opportunities to provide essential support during the company’s growth plan.

More... »

Acceleration Laboratory earns four out of five CRO Leadership Awards

Thursday, April 3, 2014 11:20 AM

Acceleration Laboratory Services, a unit of CRO Acceleration Scientific, has announced their acceptance of the 2014 CRO Leadership Awards from Life Science Leader magazine in the categories of regulatory, innovation, productivity and reliability. The CRO Leadership Awards are based on responses of more than 10,000 pharmaceutical and biopharmaceutical executives to a survey conducted by Nice Insight and sponsored by Life Science Leadermagazine. The awards recognize those contract research and service organizations that are the most highly rated by industry respondents.

More... »

Numira appoints David Raminick V.P. of sales & marketing

Friday, March 28, 2014 01:14 PM

Numira, a CRO providing high resolution, 3D imaging services, visualization software and cloud computing for the life science market, has appointed David Raminick vice president of sales and marketing.

More... »

Frank Sposato, Jr., of CFS Clinical, selected as Top IT Pro finalist

Friday, March 28, 2014 12:35 PM

Philadelphia Business Journal hasannounced the list of finalists for the 2014 Top IT Pros this week, naming Frank Sposato Jr., vice president of information technology at CFS Clinical, as one of the Top 5 IT Pros in a private company.

More... »

Quintiles appoints Stella Blackburn to lead global risk management

Friday, March 28, 2014 12:33 PM

Quintiles has appointed Stella Blackburn, M.B. B.S., vice president and global head of Risk Management for its Real-World & Late Phase Research group. Blackburn will be responsible for leading the group’s risk management efforts in the U.S., E.U., Australia and Canada. Blackburn also will develop multidisciplinary risk management services, review and assist with interpretation of pharmacovigilance legislation and ensure compliance with regulations and best practices in the conduct of pharmacovigilance and risk management activities for the company’s real-world and late phase research efforts.

More... »

Jeremiah McDole named director of Clinical R&D at StemGenex

Friday, March 21, 2014 10:09 AM

StemGenex, a provider of adult adipose-derived stem cell therapy, has named Jeremiah McDole, Ph.D., director of Clinical R&D.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 24

Tufts CSDD’s $2.6 billion price tag to develop and bring a new drug to market raises questions, criticisms

Medidata joins GlaxoSmithKline in study to evaluate the impact of wearing mobile devices in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs